BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28769006)

  • 1. Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo.
    Wang ZS; Huang HR; Zhang LY; Kim S; He Y; Li DL; Farischon C; Zhang K; Zheng X; Du ZY; Goodin S
    Biol Pharm Bull; 2017; 40(8):1247-1254. PubMed ID: 28769006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
    He Y; Huang H; Farischon C; Li D; Du Z; Zhang K; Zheng X; Goodin S
    Oncol Rep; 2017 Feb; 37(2):953-960. PubMed ID: 28075470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.
    Chen X; Liu Y; Wu J; Huang H; Du Z; Zhang K; Zhou D; Hung K; Goodin S; Zheng X
    Cancer Genomics Proteomics; 2016; 13(2):151-60. PubMed ID: 26912805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.
    Huang H; Chen X; Li D; He Y; Li Y; Du Z; Zhang K; DiPaola R; Goodin S; Zheng X
    PLoS One; 2015; 10(12):e0144293. PubMed ID: 26630272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.
    Wang H; Cui XX; Goodin S; Ding N; Van Doren J; Du Z; Huang MT; Liu Y; Cheng X; Dipaola RS; Conney AH; Zheng X
    Oncol Rep; 2014 Feb; 31(2):835-41. PubMed ID: 24296978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells.
    Wang Z; Zhang L; Wan Z; He Y; Huang H; Xiang H; Wu X; Zhang K; Liu Y; Goodin S; Du Z; Zheng X
    Pathol Oncol Res; 2020 Jan; 26(1):209-216. PubMed ID: 29796873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
    Zheng X; Cui XX; Gao Z; Zhao Y; Lin Y; Shih WJ; Huang MT; Liu Y; Rabson A; Reddy B; Yang CS; Conney AH
    Cancer Prev Res (Phila); 2010 Jan; 3(1):114-24. PubMed ID: 20051379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.
    Huang H; Cui XX; Chen S; Goodin S; Liu Y; He Y; Li D; Wang H; Van Doren J; Dipaola RS; Conney AH; Zheng X
    Anticancer Res; 2014 Jul; 34(7):3357-63. PubMed ID: 24982340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
    Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
    Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer.
    Banerjee S; Hussain M; Wang Z; Saliganan A; Che M; Bonfil D; Cher M; Sarkar FH
    Cancer Res; 2007 Apr; 67(8):3818-26. PubMed ID: 17440096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
    J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenethyl isothiocyanate in combination with dibenzoylmethane inhibits the androgen-independent growth of prostate cancer cells.
    Huang H; He Y; Zhang L; Xiang H; Li D; Liu W; Xu XT; Goodin S; Zhang K; Zheng X
    Food Funct; 2018 Apr; 9(4):2398-2408. PubMed ID: 29595853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
    Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
    Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
    Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    Ding N; Cui XX; Gao Z; Huang H; Wei X; Du Z; Lin Y; Shih WJ; Rabson AB; Conney AH; Hu C; Zheng X
    Int J Oncol; 2014 Jun; 44(6):2139-45. PubMed ID: 24647860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.